Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Koh

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Expert Opinion on Investigational Drugs|September 6, 2021
Hepatitis D virus (HDV): investigational therapeutic agents in clinical trialsBilal Asif, Christopher Koh
Clinical Liver Disease|June 13, 2019
Approach to the diagnosis of portal hypertensionChristopher Koh, Theo Heller
Gastroenterology|June 17, 2020
Coronavirus Disease-19 Has Come Home to Roost in GastroenterologyChristopher Koh, T Jake Liang
Antiviral Research|January 29, 2014
What is the future of ribavirin therapy for hepatitis C?Christopher Koh, T Jake Liang
Journal of Hepatology|November 19, 2008
Settling the "score" with liver cancerChristopher Koh, T Jake Liang
Gastroenterology|February 8, 2018
Black Smoke Arising in the Duodenum After Liver Biopsy: What Does the Smoke Signal Mean?Ehsan Chitsaz, Venkatesh Krishnasammy, Christopher Koh
Hepatology (Baltimore, Md.)|November 7, 2017
ReplyChristopher Koh, Sasan Sakiani, Theo Heller
Journal of Viral Hepatitis|February 5, 2022
Chronic hepatitis D-What is changing?David Yardeni, Theo Heller, Christopher Koh
Gastroenterology Clinics of North America|May 12, 2020
Hepatitis Delta: Prevalence, Natural History, and Treatment OptionsJulian Hercun, Christopher Koh, Theo Heller
Gastroenterology|February 4, 2010
Glowing in the dark: not always a bad thingSasan Sakiani, Christopher Koh, Theo Heller
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Expert Opinion on Investigational Drugs|September 6, 2021
Hepatitis D virus (HDV): investigational therapeutic agents in clinical trialsBilal Asif, Christopher Koh
Clinical Liver Disease|June 13, 2019
Approach to the diagnosis of portal hypertensionChristopher Koh, Theo Heller
Gastroenterology|June 17, 2020
Coronavirus Disease-19 Has Come Home to Roost in GastroenterologyChristopher Koh, T Jake Liang
Antiviral Research|January 29, 2014
What is the future of ribavirin therapy for hepatitis C?Christopher Koh, T Jake Liang
Journal of Hepatology|November 19, 2008
Settling the "score" with liver cancerChristopher Koh, T Jake Liang
Gastroenterology|February 8, 2018
Black Smoke Arising in the Duodenum After Liver Biopsy: What Does the Smoke Signal Mean?Ehsan Chitsaz, Venkatesh Krishnasammy, Christopher Koh
Hepatology (Baltimore, Md.)|November 7, 2017
ReplyChristopher Koh, Sasan Sakiani, Theo Heller
Journal of Viral Hepatitis|February 5, 2022
Chronic hepatitis D-What is changing?David Yardeni, Theo Heller, Christopher Koh
Gastroenterology Clinics of North America|May 12, 2020
Hepatitis Delta: Prevalence, Natural History, and Treatment OptionsJulian Hercun, Christopher Koh, Theo Heller
Gastroenterology|February 4, 2010
Glowing in the dark: not always a bad thingSasan Sakiani, Christopher Koh, Theo Heller
Pageof 16